Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients

Da: GRACEcast
0 0 7 anni fa
Dr. Greg Riely from Memorial Sloan-Kettering notes how he feels molecular marker results for patients with earlier stage lung cancer can potentially be valuable.

Seguici su Facebook